• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 4 fuera de 59 páginas
Examen

NRNP 6675 Final Exam | 200 Questions & Answers | Walden University

Document preview thumbnail
Vista previa 4 fuera de 59 páginas

NRNP 6675 Final Exam | 200 Questions & Answers | Walden University

Vista previa del contenido

NRNP 6675 Final Exam | 200 Questions &
Answers | Walden University
NRNP 6675 Final Exam | 200 Questions & Answers | Walden University

Examination Overview

This comprehensive 200-question final examination is designed for students enrolled in NRNP 6675:
Psychiatric Mental Health Nurse Practitioner Care Across the Lifespan II at Walden University. The
examination assesses mastery of advanced psychiatric-mental health nursing practice, including
diagnostic reasoning using the DSM-5-TR, psychopharmacological management, psychotherapeutic
modalities, neurobiological foundations, ethical-legal principles, and culturally competent care
across the lifespan. Questions are structured according to professional certification examination
standards and reflect the course learning objectives emphasizing clinical competence, differential
diagnosis, treatment planning, and interprofessional collaboration.

Table of Contents

1. Scientific Foundations & Neurobiology (Q1–Q25)

2. Psychopharmacology & Somatic Treatments (Q26–Q55)

3. Psychotherapy & Therapeutic Modalities (Q56–Q75)

4. Mood Disorders (Q76–Q95)

5. Anxiety, OCD, Trauma & Stressor-Related Disorders (Q96–Q115)

6. Schizophrenia Spectrum & Psychotic Disorders (Q116–Q135)

7. Neurodevelopmental & Neurocognitive Disorders (Q136–Q150)

8. Personality Disorders (Q151–Q160)

9. Substance Use & Addictive Disorders (Q161–Q170)

10. Legal, Ethical & Professional Practice Issues (Q171–Q185)

11. Crisis & Emergency Psychiatry (Q186–Q200)



Section 1: Scientific Foundations & Neurobiology

Q1. A PMHNP is reviewing the neurobiological basis of schizophrenia. Which dopaminergic pathway
is primarily implicated in the positive symptoms of schizophrenia?

A. Mesocortical pathway
B. Nigrostriatal pathway
C. Mesolimbic pathway
D. Tuberoinfundibular pathway

Correct Answer: C. Mesolimbic pathway




pg. 1

,Rationale: The dopamine hypothesis posits that positive symptoms of schizophrenia (hallucinations,
delusions) result from excessive dopaminergic activity in the mesolimbic pathway, which projects
from the ventral tegmental area to limbic structures. The mesocortical pathway is associated with
negative symptoms, the nigrostriatal pathway with extrapyramidal symptoms, and the
tuberoinfundibular pathway with prolactin regulation.



Q2. A PMHNP is assessing a patient with suspected neuroleptic malignant syndrome (NMS). Which
set of findings is most consistent with this diagnosis?

A. Hypothermia, bradycardia, hypotension, and decreased muscle tone
B. Hyperthermia, muscle rigidity, autonomic instability, and altered mental status
C. Hyporeflexia, sedation, weight gain, and hyperglycemia
D. Tardive dyskinesia, akathisia, and parkinsonism

Correct Answer: B. Hyperthermia, muscle rigidity, autonomic instability, and altered mental status

Rationale: NMS is a life-threatening condition characterized by the tetrad of hyperthermia, severe
muscle rigidity ("lead-pipe"), autonomic instability (fever, tachycardia, labile blood pressure), and
altered mental status. It is associated with antipsychotic use, particularly high-potency typical
antipsychotics or rapid dose escalation. Tardive dyskinesia and akathisia are separate extrapyramidal
side effects.



Q3. Which brain structure is most closely associated with the pathophysiology of obsessive-
compulsive disorder (OCD)?

A. Amygdala
B. Hippocampus
C. Orbitofrontal cortex and caudate nucleus
D. Substantia nigra

Correct Answer: C. Orbitofrontal cortex and caudate nucleus

Rationale: OCD is associated with dysfunction in the cortico-striato-thalamo-cortical circuitry,
particularly involving the orbitofrontal cortex, anterior cingulate cortex, and caudate nucleus. This
circuit dysregulation produces the intrusive thoughts (obsessions) and repetitive behaviors
(compulsions) characteristic of OCD.



Q4. A PMHNP is evaluating a patient for possible serotonin syndrome. Which combination of
medications most commonly precipitates this condition?

A. Lithium and haloperidol
B. Fluoxetine and tramadol
C. Clozapine and valproate
D. Bupropion and naltrexone

Correct Answer: B. Fluoxetine and tramadol




pg. 2

,Rationale: Serotonin syndrome results from excessive serotonergic activity, typically when two or
more serotonergic agents are combined. Fluoxetine (an SSRI) and tramadol (which has serotonergic
properties) together increase serotonin levels, potentially causing the triad of mental status changes,
autonomic hyperactivity, and neuromuscular abnormalities.



Q5. A 28-year-old patient presents with depressed mood, anhedonia, insomnia, and feelings of
worthlessness for the past 6 weeks. The PMHNP should first:

A. Initiate sertraline 50 mg daily
B. Obtain a comprehensive psychiatric evaluation including suicide risk assessment
C. Refer for electroconvulsive therapy
D. Start cognitive behavioral therapy alone

Correct Answer: B. Obtain a comprehensive psychiatric evaluation including suicide risk
assessment

Rationale: The priority is to conduct a comprehensive psychiatric evaluation, including assessment
of suicide risk, before initiating treatment. This guides diagnosis, safety planning, and treatment
selection. Medication and psychotherapy follow assessment.



Q6. Which of the following are risk factors for neuroleptic malignant syndrome (NMS)?

A. Rapid dose escalation of antipsychotics
B. Parenteral route of antipsychotic administration
C. Use of higher potency typical antipsychotics
D. All of the above

Correct Answer: D. All of the above

Rationale: Risk factors for NMS include rapid dose escalation, parenteral administration, use of high-
potency typical antipsychotics, dehydration, agitation, and male gender. All listed options are
recognized risk factors.



Q7. A discrepancy between anatomical sex and gender is known as:

A. Gender dysphoria
B. Gender discordance
C. Sexual dysfunction
D. Paraphilic disorder

Correct Answer: B. Gender discordance

Rationale: Gender discordance refers to the discrepancy between an individual's assigned sex at
birth and their experienced gender identity. Gender dysphoria is the distress that may accompany
this discrepancy and is a DSM-5-TR diagnosis.




pg. 3

, Q8. Antipsychotic medication provides D2 blockage in the mesocortical pathway causing which of
the following effects?

A. Increases positive symptoms
B. Increases extrapyramidal symptoms
C. Reduces negative symptoms
D. Reduces positive symptoms

Correct Answer: C. Reduces negative symptoms

Rationale: D2 blockade in the mesocortical pathway is thought to help reduce negative symptoms of
schizophrenia (flat affect, avolition, alogia). However, excessive blockade in this pathway may also
contribute to cognitive and negative symptom worsening in some patients.



Q9. According to the dopamine hypothesis of schizophrenia, which statement best describes the
underlying neurobiological mechanism?

A. Schizophrenia results from deficient dopaminergic activity in all brain regions
B. Schizophrenia results from excessive dopaminergic activity, particularly in the mesolimbic
pathway
C. Schizophrenia is caused by a single genetic mutation affecting dopamine receptor density
D. Schizophrenia results from excessive serotonergic activity

Correct Answer: B. Schizophrenia results from excessive dopaminergic activity, particularly in the
mesolimbic pathway

Rationale: The dopamine hypothesis posits that positive symptoms of schizophrenia result from
excessive dopaminergic activity in the mesolimbic pathway, while negative symptoms may relate to
hypodopaminergic activity in the mesocortical pathway.



Q10. Which of the following is true regarding the blood-brain barrier and psychotropic medications?

A. All psychotropic medications cross the blood-brain barrier freely
B. Only lipophilic medications can cross the blood-brain barrier
C. The blood-brain barrier has no effect on psychotropic medication efficacy
D. Psychotropic medications are actively transported out of the brain

Correct Answer: B. Only lipophilic medications can cross the blood-brain barrier

Rationale: The blood-brain barrier restricts passage of hydrophilic substances. Psychotropic
medications must be sufficiently lipophilic to cross into the central nervous system and exert their
therapeutic effects. This property influences drug selection and dosing.



Q11. A PMHNP is assessing a patient who has been taking clozapine for 3 months. Which laboratory
monitoring parameter is most critical for this patient?

A. Absolute neutrophil count
B. Serum lithium level




pg. 4

Información del documento

Subido en
12 de octubre de 2026
Número de páginas
59
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$22.98

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
4
Seguidores
1
Artículos
379
Última venta
1 día hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes